SFTPD and metabolic syndrome: Complications of diabetes, including primary effects of high glucose levels, have been shown to impair SP-D binding in a murine “metabolic syndrome” model, which correlates with the increased risk of respiratory infection in diabetes mellitus (Reading et al., 1998).